Institute of Militalry Medicine, Nanjing Jinling Hospital, Medical School, Nanjing University, Nanjing, 210002, China Department of Epidemiology, Nanjing Medical University, Nanjing, 210029, China;
Institute of Militalry Medicine, Nanjing Jinling Hospital, Medical School, Nanjing University, Nanjing, 210002, China;
Institute of Militalry Medicine, Nanjing Jinling Hospital, Medical School, Nanjing University, Nanjing, 210002, China;
Institute of Militalry Medicine, Nanjing Jinling Hospital, Medical School, Nanjing University, Nanjing, 210002, China;
Department of Epidemiology, Nanjing Medical University, Nanjing, 210029, China;
Department of Epidemiology, Nanjing Medical University, Nanjing, 210029, China;
the F protein; HepG2; apoptosis; tumor necrosis factora; flow cytometry; DNA Ladder;
机译:OL-001放线菌素D和肿瘤坏死因子-a在稳定转染了丙型肝炎病毒1b亚型F蛋白的HepG2细胞中诱导的增殖和抗凋亡
机译:从有或没有肝细胞癌患者中获得的丙型肝炎病毒1b亚型核心蛋白及其移码产物F蛋白的比较序列分析
机译:感染HCV 1b亚型的患者的肝细胞癌风险和丙型肝炎病毒(HCV)NS3蛋白氨基末端的二级结构
机译:丙型肝炎病毒亚型1B的F蛋白在体外抑制人肝细胞癌Hepg2细胞凋亡
机译:e药提取物对人肝癌细胞HepG2和多药耐药人肝癌细胞R-HepG2的抗癌活性及其作用机制。
机译:蛋白酶抑制剂9的过表达与人肝细胞癌的预后不良以及体外HepG2细胞的增殖和凋亡有关
机译:OL-001放线菌素D和肿瘤坏死因子-α在稳定转染丙型肝炎病毒1b亚型F蛋白的HepG2细胞中诱导的增殖和抗凋亡